Cassava Sciences to Hold Conference Call on Monday, September 14, 2020 at 8:30 am ET
Cassava Sciences, Inc. (Nasdaq: SAVA), a clinical-stage
biotechnology company focused on Alzheimer’s disease, announced
today that it will hold a conference call on Monday, September 14th
at 8:30 a.m. Eastern Time.
Event details follow:
Monday, September 14th
8:30 a.m. Eastern Time
The dial-in number for international callers is
1-212-231-2929. A replay of the webcast will remain available in
the ‘Investors’ section of Cassava Sciences’ website,
www.CassavaSciences.com, for 90 days following the conference. In
addition, a telephonic replay of the call will be available until
September 28, 2020. The replay dial-in numbers are 1-844-512-2921
for domestic callers and 1-412-317-6671 for international callers.
Please use the replay conference ID number 21969265.
About Cassava Sciences,
Inc.Cassava Sciences’ mission is to discover and develop
innovations for chronic, neurodegenerative conditions. Over the
past 10 years, Cassava Sciences has combined state-of-the-art
technology with new insights in neurobiology to develop novel
solutions for Alzheimer’s disease. Cassava Sciences owns worldwide
development and commercial rights to its research programs in
Alzheimer’s disease, and related technologies, without royalty
obligations to any third-party.
For More Information
Contact:Eric Schoen, Chief Financial OfficerCassava
Sciences, Inc.eschoen@CassavaSciences.com(512) 501-2450